Tissue Heavy Metals in Liver Diseases.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 26 11 2021
revised: 03 05 2022
accepted: 22 05 2022
pubmed: 20 8 2022
medline: 9 11 2022
entrez: 19 8 2022
Statut: ppublish

Résumé

Our objective was to determine the levels of heavy metals, oxidants, and antioxidants in liver tissue of patients with chronic liver disease (CLD) compared with healthy living liver donors (LLDs). We obtained liver specimens from patients undergoing liver transplant for CLD. Samples were also obtained from LLDs. Biochemical analyses were performed on all samples, and the levels of liver tissue, heavy metal, and oxidant-antioxidants biomarker levels in patients with CLD were compared with those measured in LLDs. One hundred and eighteen individuals were included for analyses. Fifty-nine were patients with CLD, and 59 were LLDs. The median levels of liver tissue of superoxide dismutase (P = .009), glutathione peroxidase (P = .042), total oxidant status (P = .006), oxidative stress index (P < .001), and copper (P = .035) were prominently more elevated in CLD than LLDs. On the other hand, the median levels of liver tissue of cadmium (P < .001), selenium (P = .042), and zinc (P < .001) levels were more elevated in the LLDs than patients with CLD. The 2 groups were similar in terms of total antioxidant status, manganese, arsenic, and lead levels. Superoxide accumulation in the liver was higher in patients with CLD. Concerning heavy metals, only the median tissue copper was elevated in patients with CLD with higher Cu/Zn ratio. Cadmium, selenium, and zinc were significantly higher in the healthy LLDs.

Sections du résumé

BACKGROUND BACKGROUND
Our objective was to determine the levels of heavy metals, oxidants, and antioxidants in liver tissue of patients with chronic liver disease (CLD) compared with healthy living liver donors (LLDs).
METHODS METHODS
We obtained liver specimens from patients undergoing liver transplant for CLD. Samples were also obtained from LLDs. Biochemical analyses were performed on all samples, and the levels of liver tissue, heavy metal, and oxidant-antioxidants biomarker levels in patients with CLD were compared with those measured in LLDs.
RESULTS RESULTS
One hundred and eighteen individuals were included for analyses. Fifty-nine were patients with CLD, and 59 were LLDs. The median levels of liver tissue of superoxide dismutase (P = .009), glutathione peroxidase (P = .042), total oxidant status (P = .006), oxidative stress index (P < .001), and copper (P = .035) were prominently more elevated in CLD than LLDs. On the other hand, the median levels of liver tissue of cadmium (P < .001), selenium (P = .042), and zinc (P < .001) levels were more elevated in the LLDs than patients with CLD. The 2 groups were similar in terms of total antioxidant status, manganese, arsenic, and lead levels.
CONCLUSIONS CONCLUSIONS
Superoxide accumulation in the liver was higher in patients with CLD. Concerning heavy metals, only the median tissue copper was elevated in patients with CLD with higher Cu/Zn ratio. Cadmium, selenium, and zinc were significantly higher in the healthy LLDs.

Identifiants

pubmed: 35985878
pii: S0041-1345(22)00412-2
doi: 10.1016/j.transproceed.2022.05.029
pii:
doi:

Substances chimiques

Copper 789U1901C5
Cadmium 00BH33GNGH
Antioxidants 0
Selenium H6241UJ22B
Lead 2P299V784P
Metals, Heavy 0
Zinc J41CSQ7QDS
Oxidants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1859-1864

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Sami Akbulut (S)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey. Electronic address: akbulutsami@gmail.com.

Burak Isik (B)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Muhammed Mehdi Uremis (M)

Department of Medical Biochemistry, Inonu University Faculty of Medicine, Malatya, Turkey.

Ufuk Gunay Dogan (UG)

Fuel-Oil Analysis Laboratory, Inonu University Rectorate, Malatya, Turkey.

Tevfik Tolga Sahin (TT)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Kemal Baris Sarici (KB)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Cemalettin Koc (C)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Khaled Demyati (K)

Department of Surgery, An-Najah National University Hospital, An-Najah National University, Nablus, Palestine.

Abuzer Dirican (A)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Yusuf Turkoz (Y)

Department of Medical Biochemistry, Inonu University Faculty of Medicine, Malatya, Turkey.

Sezai Yilmaz (S)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH